Calumet (CLMT) analyst forecast and price target
Analyst forecast
Consensus of 6 analyst ratings
Based on 4 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $75.00 from $60.00 | Sep 2, 2026 |
| UBS | Maintained | Neutral | $47.00 from $26.00 | Aug 25, 2026 |
| Goldman Sachs | Maintained | Neutral | $45.00 from $40.00 | Aug 18, 2026 |
| TD Cowen | Maintained | Hold | $40.00 from $34.00 | Aug 12, 2026 |
| Goldman Sachs | Maintained | Neutral | $40.00 from $36.00 | Jul 30, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $60.00 from $33.00 | Mar 30, 2026 |
| Goldman Sachs | Maintained | Buy | $34.00 from $24.00 | Mar 12, 2026 |
| Goldman Sachs | Maintained | Buy | $24.00 from $20.00 | Jan 30, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $33.00 | Nov 10, 2025 |
| Goldman Sachs | Maintained | Buy | $20.00 from $15.00 | Oct 22, 2025 |
| UBS | Maintained | Neutral | $13.25 from $12.00 | Aug 12, 2025 |
| Wells Fargo | Maintained | Overweight | $21.00 from $23.00 | May 14, 2025 |
| B of A Securities | Initiated Coverage | Buy | $15.00 | May 13, 2025 |
| Goldman Sachs | Maintained | Buy | $14.00 from $16.00 | Apr 30, 2025 |
| Wells Fargo | Maintained | Overweight | $23.00 from $28.00 | Apr 9, 2025 |
| UBS | Upgraded | Sell → Neutral | $12.00 from $15.00 | Mar 17, 2025 |
| Wells Fargo | Maintained | Overweight | $28.00 from $29.00 | Mar 5, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $33.00 | Mar 3, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $33.00 | Feb 12, 2025 |
| UBS | Downgraded | Neutral → Sell | $15.00 from $20.50 | Feb 4, 2025 |
Frequently asked questions
What is the price target for CLMT stock?
The average 12-month analyst price target for Calumet (CLMT) is $51.75, with a high estimate of $75.00 and a low of $40.00, across 4 analysts.
Is CLMT a buy, sell, or hold?
Analysts covering Calumet currently average a Hold rating: 2 buy, 4 hold and 0 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for CLMT?
The average price target of $51.75 implies 11.14% downside from the last price of $58.24.
What is the latest analyst rating on CLMT?
On Sep 2, 2026, HC Wainwright & Co. maintained Calumet at Buy with a price target of $75.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.